NA Selank Amidate
Also known as N-acetyl Selank amidate, NA-Selank
A modified form of the heptapeptide Selank, described as carrying an N-terminal acetyl group and a C-terminal amide. No peer-reviewed studies of this specific modification are indexed on PubMed.
Preclinical research
Size
1 option- Catalog no.
- NSK30
- Specification
- 30ml*10vials
- Per kit
- 10 vials
For laboratory research use only. Not for human or animal consumption. Buyers must be 21 or older.
Overview
NA Selank Amidate is described by suppliers as Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) with an acetyl group added at the N-terminus and the C-terminal carboxyl group converted to an amide. Peptide chemists commonly use these end modifications to reduce breakdown by exopeptidases, but no indexed study has measured the stability, potency, or pharmacology of this specific compound. Any discussion of its mechanism therefore relies on research with unmodified Selank, which has been studied in rodent anxiety and stress models, in vitro enzyme assays, and small clinical studies in Russia. Published research on the modified form itself is effectively absent.
Class: Modified Selank analogue (N-acetylated, C-amidated)
Mechanism of action
How the compound acts, as described in the literature.
N-acetylation and C-amidation are standard end-capping modifications used to slow exopeptidase degradation of peptides; their effect on the stability of Selank has not been reported.
Parent Selank inhibits enkephalin-degrading enzymes in human plasma in vitro; whether the modified form retains this activity is unknown.
Parent Selank altered GABAergic neurotransmission gene expression in rat cortex; no comparable data exist for the acetylated, amidated analogue.
Published research
Selected studies, each linked to its PubMed record. Summaries describe what the studies reported.
No indexed studies are listed for this product yet.
Evidence & safety
What the research does not show, and the adverse events and regulatory status it reports.
No indexed study has examined this compound, so its stability, activity, and safety are unknown, and findings for unmodified Selank cannot be assumed to apply. It is not an approved medicine in any jurisdiction.
Specifications
All sizes, exactly as catalogued.
| Catalog no. | Product | Specification | Vials per kit |
|---|---|---|---|
| NSK30 | NA Selank Amidate | 30ml*10vials | 10 |
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease. Research summaries are provided for educational purposes and do not describe this product’s use.